SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending amidst heated discussions surrounding its namesake's push to acquire Greenland and recent threats of tariffs against European nations. This aggressive stance is viewed by supporters as a powerful negotiation tactic and a move to assert U.S. dominance, while critics express deep concern over potential economic disruption, diplomatic strain, and geopolitical instability. The ongoing debate highlights extreme market volatility driven by political headlines and the polarized community reactions to these developments.

KiboShib (KIBSHI) is the first AI-generated meme coin. On December 8th 2022, AI was tasked with creating a meme coin. It all started as a joke, but the idea which was proposed by the AI is so powerful that nobody could resist! The AI even suggested a logo design which later has been fed to the AI image generator. The age of AI is upon us, and KiboShib stands for exploring the capabilities of AI with a hopeful outlook.

KiboShib

KIBSHI is generating significant buzz, driven by its narrative as the "first AI-generated meme coin" and its recent impressive gains. Community discussion highlights its low market cap and potential to be the next major contender in the evolving meme coin landscape, particularly within the Ethereum ecosystem, as it eyes a massive altcoin season run.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network ($ROSE) is currently trending with significant community discussion centered on its robust privacy-preserving capabilities and its expanding role in the confidential AI and Web3 sectors. Users are highlighting recent developments, integrations with other ecosystems, and new grants as catalysts, positioning ROSE as a potentially undervalued asset with strong utility in a rapidly evolving market.

Spell Token

Spell Token is trending with a highly divided community sentiment, marked by aggressive dip-buying in anticipation of an "Alt Season" and potential positive impacts from the "Clarity Act" and AI developments. However, many remain concerned about token dilution and its historical volatility, with some labeling it as prone to pump-and-dump cycles.

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Salt Lake City, UT.

PACS Group Inc.

PACS Group Inc. is trending amid its latest business updates, including completed financial restatements and regained SEC compliance. The community is actively debating the company's valuation gap compared to peers in the growing post-acute healthcare sector, with many anticipating a re-rating following new analyst coverage, despite lingering discussions about prior allegations and ongoing inquiries.

Intercontinental Exchange, Inc. engages in the provision of market infrastructure, data services and technology solutions. It operates through the following segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The Exchanges segment operates marketplace technology for the listing, trading, and clearing of derivatives contracts and financial securities, as well as data and connectivity services. The Fixed Income and Data Services segment provides fixed income pricing, reference data, indices, analytics, and execution services as well as global credit default swap, or CDS, clearing, and multi-asset class data delivery technology. The Mortgage Technology segment provides a technology platform that offers digital workflow tools to address inefficiencies and mitigate risks that exist in the US residential mortgage market lifecycle from application through closing, servicing, and the secondary market. The company was founded by Jeffrey C. Sprecher in 2000 and is headquartered in Atlanta, GA.

Intercontinental Exchange Inc

Intercontinental Exchange (ICE) is trending due to its significant strategic investment in Polymarket, signaling a major entry into prediction markets and the broader digital asset space. The community is actively discussing this move, seeing it as a crucial step for the NYSE parent company to lead in tokenized securities trading with ambitions for 24/7 operations and instant settlement. This positions ICE at the forefront of merging traditional finance infrastructure with innovative blockchain technology.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

Mimedx Group is actively discussed amid significant community concern regarding upcoming CMS reimbursement changes for skin substitutes, anticipated to drastically alter the wound care market. Many investors fear substantial revenue reductions for MDXG in 2026 as products reliant on high prices and lacking clinical data face coverage losses, leading to intense criticism of management's perceived inaction and silence. Conversely, a smaller group believes these changes will weed out unethical competitors, positioning MDXG's clinically proven products for long-term market share gains despite short-term uncertainty.

ChargePoint Holdings, Inc. operates as an electric vehicle charging network provider. It designs, develops and markets networked electric vehicle charging system infrastructure and its Cloud Services enable consumers the ability to locate, reserve, authenticate and transact electric vehicle charging sessions. The firm provides an open platform providing real-time information about charging sessions and control, support and management of the networked charging systems. This network provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. The company was founded in 2007 and is headquartered in Campbell, CA.

ChargePoint Holdings Inc - Ordinary Shares - Class A

ChargePoint Holdings Inc

ChargePoint is trending following recent financial updates that present a mixed picture of revenue growth and continued losses, prompting a highly polarized community discussion. While some investors point to strategic partnerships and progress in subscription revenue as signs of future potential in the EV infrastructure sector, many others remain deeply skeptical given the company's history of unprofitability and concerns about further share dilution. This divergence fuels active options trading as participants weigh the challenges and long-term prospects within the evolving electric vehicle market.

Rydex Investments - Invesco CurrencyShares British Pound Sterling Trust

Invesco CurrencyShares British Pound Sterling Trust

The Invesco CurrencyShares British Pound Sterling Trust is trending as markets reprice the Bank of England's policy path following cooler UK inflation data, fueling expectations for significant rate cuts. The community is actively discussing the Pound's outlook, weighing a dovish BoE against broader concerns about UK fiscal conditions and the dynamic strength of the US Dollar.

Forum Energy Technologies, Inc. designs, manufactures, and distributes products to the oil and natural gas industry. It operates through the Drilling and Completions and Artificial Lift and Downhole segments. The Drilling and Completions segment designs, manufactures and supplies products and solutions to the drilling, subsea, coiled tubing, well stimulation and intervention markets, including applications in oil and natural gas, renewable energy, defense and communications. The Artificial Lift and Downhole segment designs, manufactures and supplies products and solutions for the artificial lift, production and infrastructure markets. The company was founded in 2005 and is headquartered in Houston, TX.

Forum Energy Technologies Inc

Forum Energy Technologies is a top discussion point as investors keenly anticipate significant capital returns through debt reduction and potential share buybacks, driven by robust free cash flow generation and the transformative impact of the Variperm acquisition. The community widely views FET as substantially undervalued compared to its peers, finding conviction in its strong financial health amidst varying activity levels in the oilfield services sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 1,800 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 1,800 shares of the stock in a transaction dated Tuesday, January 13th. The stock was purchased at an average...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 2,900 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 2,900 shares of the company's stock in a transaction dated Monday, January 12th. The shares were acquired at an...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases 2,900 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 2,900 shares of the business's stock in a transaction that occurred on Monday, January 12th. The shares were...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Buys $91,848.00 in Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 4,300 shares of Greenwich LifeSciences stock in a transaction that occurred on Wednesday, December 31st. The...

Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 4,300 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 4,300 shares of the business's stock in a transaction on Wednesday, December 31st. The stock was acquired at an...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases $63,017.00 in Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 2,900 shares of Greenwich LifeSciences stock in a transaction that occurred on Tuesday, December 30th. The...

Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Buys 2,900 Shares

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 2,900 shares of the company's stock in a transaction on Tuesday, December 30th. The shares were acquired at an...

FY2025 Earnings Estimate for GLSI Issued By HC Wainwright

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Equities researchers at HC Wainwright issued their FY2025 earnings estimates for shares of Greenwich LifeSciences in a report issued on...

What's Going On With Greenwich LifeSciences Stock Monday?

Greenwich LifeSciences shares are trading higher Monday after the company announced it extended its lock-up period to Sept. 30, 2026.read more...

<ul class="summary-bullets"><li>During this period, insiders will be restricted from selling their shares unless the board decides otherwise.</li><li>The lock-up helps align insiders with long-term shareholders while supporting the Phase III FLAMINGO-01 study of GLSI-100, CEO Snehal Patel said.</li><li>GLSI shares have been on a rally since the company announced progress in the FLAMINGO-01 trial on December 15, gaining more than 130%.</li></ul>Shares of Greenwich LifeSciences Inc. (GLSI) jumped 25% on Monday, to their highest since February 2022, after the company’s Board extended the lock-up period on shares held by directors, officers, and pre-IPO investors&nbsp;by six months, through Sept. 30, 2026 – roughly six years after the company’s initial public offering (IPO).During this period, insiders will be restricted from selling their shares unless the board decides otherwise. Any sales after that date would still be limited under a structured “leak-out” plan.Chief Executive Officer Snehal Patel said the longer lock-up helps align insiders with long-term shareholders while supporting the Phase III FLAMINGO-01 study of GLSI-100, an immunotherapy to prevent breast cancer recurrence.<a href="https://stocktwits.com/symbol/GLSI">GLSI shares</a> have been on a rally since the company announced progress in the FLAMINGO-01 trial on December 15, gaining more than 130%.&nbsp; The stock is on track to post its biggest monthly gain in five years.<h2 class="st-heading-2">FLAMINGO-01 Trial Progress</h2>FLAMINGO-01 is a global Phase III study testing GLSI-100 in HER2-positive breast cancer patients following standard treatment. More than 1,000 patients have been screened, with enrollment continuing across U.S. and European sites, the company said. Around 140 sites are actively enrolling patients, with plans to expand further in 2026.Preliminary data from the open-label non-HLA-A*02 arm, involving 250 treated patients, showed around 80% reduction in recurrence rates following the primary immunization series, which consists of six injections over six months. These early results appear consistent with findings from the company’s Phase IIb trial, though Greenwich cautioned that the data remains preliminary and subject to further review.In its earlier Phase IIb trial, GLSI-100 demonstrated an 80% or greater reduction in metastatic breast cancer recurrences over five years in treated patients, with a strong immune response and a favorable safety profile. These results underpin the design and expectations of the ongoing Phase III study, the company added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits remained in the ‘extremely bullish’ territory over the past 24 hours, amid ‘extremely high’ message volumes. GLSI was among the top trending tickers on the platform at the time of writing.<img src="https://news.stocktwits-cdn.com/GLSI_png_c5b2b8ee32.webp" alt="GLSI.png">One user believes that, given the large volume, a ‘big player’ could be buying in.<stembedurl>https://stocktwits.com/Whitevalkyrie01/message/640311249</stembedurl>Year-to-date, GLSI has gained more than 120%.Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/copper-sees-strong-rally-this-year-but-consolidation-in-2026/cL75wm5RExf">Copper Saw A Massive Rally This Year – Goldman Sachs Sees Consolidation In 2026</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did GLSI Stock Surge 25% Today?

The company’s Board extended the lock-up on shares held by directors, officers, and pre-IPO investors through Sept. 30, 2026.

Equity

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Current Price	$24.88
Prev Close	$27.19
Open	$27.51
Dividend Yield	0.00%
50-Day Moving Average	$13.94
Beta	1.23
Avg. Volume	687,248.50
PE Ratio	-16.99

52-Week High	$32.91
52-Week Low	$7.78
Market Capitalization	$344.7M
EPS (Annual)	-$1.21
Price to Book	157.08
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

GLSI
Greenwich LifeSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLSI News

GLSIGreenwich LifeSciences Inc